Giant steps: Dyno closes $100M series A round for advanced capsid engineering

Press

May 6, 2021

BioWorld

Press

Published

May 6, 2021

More like this

Dyno Therapeutics to Present Breakthrough Data on AAV Gene Delivery to the CNS, Eye, and Muscle at the 28th Annual Meeting of the American Society of Gene & Cell Therapy

Dyno Therapeutics to Present Breakthrough Data on AAV Gene Delivery to the CNS, Eye, and Muscle at the 28th Annual Meeting of the American Society of Gene & Cell Therapy

Low-N OpenFold fine-tuning improves peptide design without additional structures

October 4, 2024

Low-N OpenFold fine-tuning improves peptide design without additional structures

October 4, 2024

Generative design for gene therapy: An in vivo validated method

October 27, 2023

Generative design for gene therapy: An in vivo validated method

October 27, 2023

Challenges and opportunities of machine-guided capsid engineering for gene therapy

Cell & Gene Therapy Insights

February 26, 2019

Challenges and opportunities of machine-guided capsid engineering for gene therapy

Cell & Gene Therapy Insights

February 26, 2019